Diagram showing Hippocampus, an area affected by Alzheimer’s Disease (credits Appendix A)
Small and Duff’s Dual Pathway hypothesis is widely cited (e.g see here). The interested reader is referred to the paper above. However I have outlined the salient features below as I have found them
(1) The Amyloid Cascade Hypothesis does not appear to explain all cases of Alzheimer’s Disease particularly when this is late in onset.
(2) Tau gene mutations are described as leading to Frontotemporal Dementia rather than Alzheimer’s Type Dementia
(3) A dual pathway is hypothesised which describes processes upstream to the Amyloid deposition and tau phosphorylation and which influence both
(4) Small and Duff identify APOE4, GSK and the Retromer sorting pathway as three examples of upstream drivers
(5) When Amyloid deposition is absent or minimal but the other elements are present this has implications for Amyloid reducing strategies
Appendix A – Credits
Picture by FG Designs. Creative Commons License.
Index: There are indices for the TAWOP site here and here
Twitter: You can follow ‘The Amazing World of Psychiatry’ Twitter by clicking on this link.
TAWOP Channel: You can follow the TAWOP Channel on YouTube by clicking on this link.
Responses: If you have any comments, you can leave them below or alternatively e-mail justinmarley17@yahoo.co.uk.
Disclaimer: The comments made here represent the opinions of the author and do not represent the profession or any body/organisation. The comments made here are not meant as a source of medical advice and those seeking medical advice are advised to consult with their own doctor. The author is not responsible for the contents of any external sites that are linked to in this blog.
Conflicts of Interest: *For potential conflicts of interest please see the About section.
[…] the widely cited Dual Pathway Hypothesis which relates to Alzheimer’s Disease, Small and Duff hypothesised that although both tau and […]
LikeLike
[…] is a good overview of the endomembrane system at the Bleier Biology YouTube Channel. Small and Duff hypothesise that the Retromer Sorting Pathway plays a role in Alzheimer’s Disease. The […]
LikeLike
[…] was reviewing Small and Duff’s Dual Pathway Hypothesis relating to Alzheimer’s Disease and I focused on the Retromer Sorting Pathway. One component […]
LikeLike
[…] 35) is a protein which is part of the Retromer Complex. This protein is specifically referenced in Small and Duff’s Dual Pathway Hypothesis relating to Alzheimer’s […]
LikeLike
[…] 27 papers (2005-2017). Interestingly the first paper is by Small and colleagues. (relevant to Small and Duffy’s Dual Pathway Hypothesis of Alzheimer’s Disease). In this paper, the researchers hypothesise a mechanism of action for […]
LikeLike
[…] of the PART hypothesis which was driven by histopathological findings. There was also a look at Small and Duff’s Dual Pathway hypothesis (DPH) for Alzheimer’s Disease which focused on explaining the findings in late-onset […]
LikeLike
[…] The Wellcome Trust have created this video on their YouTube channel illustrating the processes involved in transporting lipids around the body. The reason I have included this video here is that Apolipoprotein is a key molecule in lipid transport and Apolipoprotein E (and more specifically the E4 allele) is a risk factor for Alzheimer’s Disease. Furthermore APOE4 is described as a regulator of Alzheimer’s pathology upstream of both Tau and Amyloid in Small and Duff’s Dual Pathway Hypothesis. […]
LikeLike
[…] is one of the upstream regulators of Amyloid and Tau pathology in Small and Duffy’s Dual Pathway Hypothesis of Alzheimer’s […]
LikeLike
[…] have looked at Small and Duff’s Dual Pathway Hypothesis (DPH) of Alzheimer’s Disease in previous posts. We have also looked at the enzyme Glycogen Synthase […]
LikeLike
[…] implicating GSK 3 in Alzheimer’s Disease from Small and Duff’s 2008 paper on the Dual Pathway Hypothesis […]
LikeLike
[…] of the PART hypothesis which was driven by histopathological findings. There was also a look at Small and Duff’s Dual Pathway hypothesis (DPH) for Alzheimer’s Disease which focused on explaining the findings in late-onset […]
LikeLike
[…] APOE4 is referenced as an upstream regulator of Tau and Amyloid pathology in Small and Duff’s Dual Pathway Hypothesis. In their paper, Dose and colleagues note several lines of evidence from murine studies […]
LikeLike
[…] APOE4 is referenced as an upstream regulator of Tau and Amyloid pathology in Small and Duff’s Dual Pathway Hypothesis. In their paper, Dose and colleagues note several lines of evidence that link APOE4 with […]
LikeLike